Shouxiangu

Shouxiangu (寿仙谷) is a Chinese health-products brand and listed pharmaceutical company headquartered in Wuyi County, Jinhua, Zhejiang Province. It is best known for cultivating and processing Lingzhi (reishi mushroom) and Cordyceps, which it sells as traditional supplements, health foods, and related personal-care products. The brand positions itself around the traditional Chinese wellness concept of "medicinal food homology" — ingredients that are both food and medicine — and around controlled cultivation of its raw materials. The company operates an integrated model that spans research and development, cultivation bases, processing, and retail. Its product range includes Lingzhi spore powder, Lingzhi capsules, Cordyceps products, and other traditional Chinese health supplements. Shouxiangu is listed on the Shanghai Stock Exchange's STAR Market under the ticker 603896, giving it access to public capital to expand production and distribution. Shouxiangu's identity is closely tied to its geographic origin in Zhejiang, where it maintains cultivation and production facilities. The brand targets health-conscious consumers in China, particularly those interested in traditional Chinese medicine and premium wellness products. Its official website is sxg.cn.

Shouxiangu is a Chinese enterprise rooted in Zhejiang Province's traditional cultivation of Lingzhi (reishi mushroom) and Cordyceps. The brand name, which translates roughly to "Longevity Immortal Valley," reflects its focus on traditional Chinese health and longevity products. The company developed an integrated business model combining research, cultivation, processing, and sales of traditional Chinese medicinal and health food ingredients. Over time, Shouxiangu established cultivation bases in Zhejiang, where it grows Lingzhi and Cordyceps under controlled conditions. This vertical integration allows the company to manage quality and supply of raw materials, a key selling point in the traditional supplements market. Its product portfolio expanded to include Lingzhi spore powder, capsules, and other processed health products. The company later listed on the Shanghai Stock Exchange's STAR Market under the stock code 603896, becoming a publicly traded entity. This listing provided capital for further expansion of production capacity and brand development. Shouxiangu continues to operate as a health-products company serving the Chinese market, with its official website at sxg.cn.

• Shouxiangu is listed on the Shanghai Stock Exchange's STAR Market under ticker 603896.

• Lingzhi spore powder

  A flagship traditional supplement made from reishi mushroom spores.

• Lingzhi capsules

  Capsule-format reishi supplement for convenient daily use.

• Cordyceps products

  Supplements based on Cordyceps, a traditional Chinese medicinal fungus.

• 2018

  Reishi Spore Powder Accused of False Advertising Over Anti-Cancer Implications

  In 2018, a media investigation found that offline stores of Shouxiangu, the “first Ganoderma lucidum stock,” claimed that reishi spore powder could “fight cancer” and “assist in tumor treatment,” conflating health food with traditional Chinese medicine decoction pieces; the Wuyi County Market Supervision Administration determined that its advertising constituted misleading commercial promotion. The company admitted that frontline staff might have made promotional violations and promised rectification and training. Administrative determination, company rectification.

  Source

Read more

1. 1寿仙谷官方网站sxg.cn
2. 2Reishi Spore Powder Accused of False Advertising Over Anti-Cancer Implicationsthepaper.cn
3. 3Reishi Spore Powder Accused of False Advertising Over Anti-Cancer Implicationsm.nbd.com.cn
4. 4Reishi Spore Powder Accused of False Advertising Over Anti-Cancer Implicationsjiemian.com